Novel Predictors of Outcome in Hypertrophic Cardiomyopathy
Who can take part?
The study is currently enrolling people diagnosed with hypertrophic cardiomyopathy aged between 18 and 65.
The HCMR study is well under way, with the first participant enrolled in April 2014 at research site 001. There are now 44 active sites; 22 sites in North America and 22 sites in Europe. The study is now following up the 2750 patients that were enrolled and is no longer recruiting.